David A. Santos, EVP, Chief Commercial Officer: Rigel Pharmaceuticals RIGL Sell · Filed 24/02/06

Trade details

Type: Insider sale
Amount: $6,329.13
Shares · price: 5,601 sh · $1.13 a share
Held after: 358,011 sh
Stock: Rigel Pharmaceuticals RIGL
Person: David A. SantosEVP, Chief Commercial Officer
Trade date: 24/02/02
Filed: 24/02/06
Days to filing: 4 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Rigel Pharmaceuticals trades, last 26 weeks

What else happened in Rigel Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/03~24/03/03

David A. Santos's recent trades

David A. SantosEVP, Chief Commercial Officer
SellRigel Pharmaceuticals
Sell
Rigel Pharmaceuticals
RIGL
$44.5K
2,125 sh
$44.5K
Filed 25/02/06
Traded 25/02/04
David A. SantosEVP, Chief Commercial Officer
SellRigel Pharmaceuticals
Sell
Rigel Pharmaceuticals
RIGL
$39.4K
1,796 sh
$39.4K
Filed 25/02/06
Traded 25/02/05
David A. SantosOfficer
Planned saleRigel Pharmaceuticals
Planned sale
Rigel Pharmaceuticals
RIGL
$39.4K
1,796 sh
$39.4K
Filed 25/02/05
Traded 25/02/05
David A. SantosOfficer
Planned saleRigel Pharmaceuticals
Planned sale
Rigel Pharmaceuticals
RIGL
$44.5K
2,125 sh
$44.5K
Filed 25/02/04
Traded 25/02/04
David A. SantosEVP, Chief Commercial Officer
SellRigel Pharmaceuticals
Sell
Rigel Pharmaceuticals
RIGL
$10.2K
8,918 sh
$10.2K
Filed 24/02/06
Traded 24/02/05